Back
GraniteShares 2x Long AAPL Daily ETF Vs. Neurocrine Biosciences, Inc. Industry Stock Comparison
Buy
55
AAPB
GraniteShares 2x Long AAPL Daily ETF
Last Price:
$32.45
Seasonality Move:
-9.21%
Buy
64
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$143.61
Seasonality Move:
4.8%
Buy
55
GraniteShares 2x Long AAPL Daily ETF (AAPB)
is a Buy
Is GraniteShares 2x Long AAPL Daily ETF a Buy, Sell or Hold?
-
The current GraniteShares 2x Long AAPL Daily ETF [AAPB] share price is $33.89. The Score for AAPB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AAPB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?
-
The current Neurocrine Biosciences, Inc. [NBIX] share price is $145.26. The Score for NBIX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AAPB Stock Price Chart
What is GraniteShares 2x Long AAPL Daily ETF's stock price today?
-
The GraniteShares 2x Long AAPL Daily ETF share price today is $33.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAPB is experiencing slight selling pressure.
NBIX Stock Price Chart
What is Neurocrine Biosciences, Inc.'s stock price today?
-
The Neurocrine Biosciences, Inc. share price today is $145.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
AAPB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 48.27 | Sell |
| Chaikin Money Flow: | -9688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.49 - 35.81) | Sell |
| Bollinger Bands (100): | (25.74 - 34.26) | Buy |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 44.84 | Sell |
| Chaikin Money Flow: | -297340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.8 - 154.28) | Sell |
| Bollinger Bands (100): | (135.2 - 149.32) | Buy |
AAPB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.8 | Buy |
| 20-day SMA: | 34.89 | Sell |
| 50-day SMA: | 33.53 | Buy |
| 200-day SMA: | 25.48 | Buy |
| 8-day EMA: | 33.97 | Sell |
| 20-day EMA: | 34.23 | Sell |
| 50-day EMA: | 33.09 | Buy |
| 200-day EMA: | 28.32 | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 145.54 | Sell |
| 20-day SMA: | 150.44 | Sell |
| 50-day SMA: | 146.63 | Sell |
| 200-day SMA: | 130.42 | Buy |
| 8-day EMA: | 146.9 | Sell |
| 20-day EMA: | 148.04 | Sell |
| 50-day EMA: | 146.36 | Sell |
| 200-day EMA: | 136.51 | Buy |
GraniteShares 2x Long AAPL Daily ETF Earnings Growth & AAPB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.26 per share.
GraniteShares 2x Long AAPL Daily ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||